Nageswaran Luxshmi, Wolfe Dalton L, Graham Laura J, Bateman Emma A
Parkwood Institute Research, Lawson Health Research Institute, London, Ontario, Canada.
School of Health Studies, Faculty of Health Sciences, Western University, London, Ontario, Canada.
J Spinal Cord Med. 2025 May;48(3):482-492. doi: 10.1080/10790268.2024.2420142. Epub 2024 Dec 10.
To evaluate cardiometabolic disease (CMD) in outpatients with spinal cord injury/disease (SCI/D). The study aims were to (1) estimate the prevalence of CMD risk factors in a cohort of Canadian adults with SCI/D; (2) assess whether the frequency of CMD screening aligns with evidence-based guidelines; and (3) gain a preliminary understanding of the barriers to CMD screening and/or treatment within a rehabilitation program setting.
Quality improvement initiative involving chart review extracting the presence of and frequency of screening for four CMD risk factors (obesity, hypertension, dyslipidemia, diabetes mellitus). Values were compared to evidence-based guidelines for CMD risk identification and management. Root cause analysis and focused interviews were conducted with clinic staff to identify barriers.
Academic, tertiary rehabilitation hospital.
Consecutive outpatients with SCI/D from October 2020 to December 2021 ( = 73).
43.8% of outpatients sampled had established CMD (≥3 risk factors) and 94.5% had at least one risk factor. Obesity was the most prevalent (82.2%), followed by dyslipidemia (71.7%), hypertension (46.5%), and diabetes mellitus (34.8%). Hypertension and obesity screening were completed at 14.3% and 10.4% of appointments. The frequency of dyslipidemia and diabetes mellitus screening could not be determined. Eighteen barriers to timely CMD screening and treatment intensification were identified.
The prevalence of CMD risk factors in outpatients with SCI/D was high. While approximately two of every five outpatients had established CMD, adherence to screening guidelines was poor. These findings reinforce the need for strategies to improve screening and reduce preventable harm from CMD in this vulnerable population.
评估脊髓损伤/疾病(SCI/D)门诊患者的心脏代谢疾病(CMD)。本研究的目的是:(1)估计一组加拿大成年SCI/D患者中CMD危险因素的患病率;(2)评估CMD筛查频率是否符合循证指南;(3)初步了解康复项目环境中CMD筛查和/或治疗的障碍。
质量改进计划,涉及病历审查,提取四种CMD危险因素(肥胖、高血压、血脂异常、糖尿病)的存在情况和筛查频率。将这些值与CMD风险识别和管理的循证指南进行比较。对临床工作人员进行根本原因分析和重点访谈,以识别障碍。
学术性三级康复医院。
2020年10月至2021年12月连续的SCI/D门诊患者(n = 73)。
43.8%的抽样门诊患者已确诊CMD(≥3种危险因素),94.5%的患者至少有一种危险因素。肥胖最为普遍(82.2%),其次是血脂异常(71.7%)、高血压(46.5%)和糖尿病(34.8%)。分别有14.3%和10.4%的预约完成了高血压和肥胖筛查。血脂异常和糖尿病筛查的频率无法确定。确定了18个阻碍及时进行CMD筛查和强化治疗的障碍。
SCI/D门诊患者中CMD危险因素的患病率很高。虽然每五名门诊患者中约有两名已确诊CMD,但对筛查指南的依从性较差。这些发现强化了在这一弱势群体中制定改善筛查和减少CMD可预防危害策略的必要性。